OCUMENSION THERAPEUTICSOCUMENSION THERAPEUTICSOCUMENSION THERAPEUTICS

OCUMENSION THERAPEUTICS

No trades
See on Supercharts
Market capitalization
‪4.03 B‬HKD
−0.65HKD
‪−419.66 M‬HKD
‪272.24 M‬HKD
‪320.57 M‬
Beta (1Y)
0.90

About OCUMENSION THERAPEUTICS

CEO
Ye Liu
Headquarters
Suzhou
Founded
2018
ISIN
KYG674111011
FIGI
BBG00VSF0NM2
Ocumension Therapeutics engages in the identification, development, and commercialization of ophthalmic therapies. The company was founded in 2017 and is headquartered in Suzhou, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 1477 is 5.86 HKD — it has decreased by 2.82% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange OCUMENSION THERAPEUTICS stocks are traded under the ticker 1477.
OCUMENSION THERAPEUTICS is going to release the next earnings report on Aug 23, 2024. Keep track of upcoming events with our Earnings Calendar.
1477 stock is 2.90% volatile and has beta coefficient of 0.90. Check out the list of the most volatile stocks — is OCUMENSION THERAPEUTICS there?
OCUMENSION THERAPEUTICS revenue for the last quarter amounts to ‪112.06 M‬ HKD despite the estimated figure of ‪132.15 M‬ HKD. In the next quarter revenue is expected to reach ‪162.35 M‬ HKD.
Yes, you can track OCUMENSION THERAPEUTICS financials in yearly and quarterly reports right on TradingView.
1477 stock has fallen by 0.68% compared to the previous week, the month change is a 1.68% fall, over the last year OCUMENSION THERAPEUTICS has showed a 34.53% decrease.
1477 net income for the last quarter is ‪−185.15 M‬ HKD, while the quarter before that showed ‪−235.69 M‬ HKD of net income which accounts for 21.44% change. Track more OCUMENSION THERAPEUTICS financial stats to get the full picture.
No, 1477 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 1477 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade OCUMENSION THERAPEUTICS stock right from TradingView charts — choose your broker and connect to your account.
1477 reached its all-time high on Jul 10, 2020 with the price of 43.00 HKD, and its all-time low was 4.51 HKD and was reached on Feb 5, 2024.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So OCUMENSION THERAPEUTICS technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating OCUMENSION THERAPEUTICS stock shows the sell signal. See more of OCUMENSION THERAPEUTICS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on OCUMENSION THERAPEUTICS future price: according to them, 1477 price has a max estimate of 12.27 HKD and a min estimate of 5.99 HKD. Read a more detailed OCUMENSION THERAPEUTICS forecast: see what analysts think of OCUMENSION THERAPEUTICS and suggest that you do with its stocks.